Obesity White Papers & Case Studies

  1. What Re-Acquisition In Retinal Imaging Is Really Costing Your Program 4/6/2026

    High screen failure rates and patient dropout often stem from preventable imaging errors. Learn how proactive quality control and patient-centric logistics secure critical retinal trial data.

  2. What Unified eCOA And IRT Can Unlock 4/6/2026

    See how real-time scoring and automated eligibility checks helped a global dermatology study reduce site burden, avoid manual errors, and move participants through screening with greater speed.

  3. Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads 4/1/2026

    Explore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.

  4. ICON And Medable Drive 85% eConsent Adoption In U.S. Menopause Study 4/1/2026

    A site-focused strategy drove strong eConsent adoption in a complex women’s health study, showing how tailored training and hands-on support boost engagement and compliance.

  5. Reinventing Prostate Cancer Diagnostics With An All-In-One Platform 3/31/2026

    Discover how a lean research team saved an estimated $100k and reached 95% data compliance by unifying their clinical workflow.

  6. Expand Your Range Of Data Capture 3/31/2026

    Capture patient data with total flexibility. Administer surveys on any device, switch mid-questionnaire without losing progress, and eliminate the need for specialized hardware or extra apps.

  7. From Months To Hours: MMC Medical's EDC Revolution 3/31/2026

    Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.

  8. Executing Concurrent Decentralized RCTs And RWE At Scale 3/31/2026

    See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.

  9. 3-Week Database Builds That Withstood FDA Review 3/31/2026

    Learn how a lean clinical team deployed global, regulator-ready databases in just three weeks to secure immediate Phase 3 entry and transform reproductive health research.

  10. A New Era Of ADC Development Demands A New Kind Of Partner 3/30/2026

    Explore how to navigate the evolution of antibody-drug conjugates by mastering AI-driven selection, dose optimization, and new regulatory strategies for earlier-line clinical success.